These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 612553)

  • 21. [Clinico-therapeutic aspects of Hodgkin's disease in childhood].
    Madon E; Baroncelli PG; Sacerdote A; Roberi PL; Cordero di Montezemolo L
    Minerva Pediatr; 1974 May; 26(17):898-906. PubMed ID: 4456215
    [No Abstract]   [Full Text] [Related]  

  • 22. [Serum copper in Hodgkin's disease: its relation to the anatomopathological variety, status and general signs].
    Aragón de la Cruz G; Otero Luna J; Criado Ortíz M; Polo Tolosana E
    Rev Clin Esp; 1975 Aug; 138(3):225-30. PubMed ID: 1178970
    [No Abstract]   [Full Text] [Related]  

  • 23. [Present-day treatment of Hodgkin's disease].
    Debray JM
    Therapie; 1977; 32(3):249-58. PubMed ID: 929496
    [No Abstract]   [Full Text] [Related]  

  • 24. Prognosis of Hodgkin's disease: patients who fail to remit or who relapse after combination chemotherapy.
    Sutcliffe SB; Economopoulos T; Wrigley PF; Stansfeld AG; Malpas JS
    Clin Oncol; 1980 Dec; 6(4):329-36. PubMed ID: 6161731
    [No Abstract]   [Full Text] [Related]  

  • 25. [Serum ferritin and other biological parameters as indicators of tumor activity in Hodgkin's disease].
    Hermosa V; Mazo E; Baró J; Castillo E; Cordovilla JJ; Carril J; Zubizarreta A
    Sangre (Barc); 1985; 30(2):154-8. PubMed ID: 2409612
    [No Abstract]   [Full Text] [Related]  

  • 26. Serum ceruloplasmin levels in Hodgkin's disease and malignant lymphomas in correlation with serum copper levels.
    Sirsat AV; Raste AS; Talavdekar RV; Advani SH
    Indian J Cancer; 1979 Jun; 16(2):32-4. PubMed ID: 546729
    [No Abstract]   [Full Text] [Related]  

  • 27. [DTIC--one component of ABVD combination therapy in Hodgkin's disease (author's transl)].
    Lutz D; Waldner R; Höcker P; Baumgartner G
    Wien Klin Wochenschr; 1978 Dec; 90(24):876-7. PubMed ID: 741755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Gonadal hypotrophy and acute leukemia after chemotherapy for Hodgkin's disease. Report of a case (author's transl)].
    Lebreton C; Grange MJ; Tchernia G; Schweisguth O
    Arch Fr Pediatr; 1981 Nov; 38(9):697-9. PubMed ID: 6949500
    [No Abstract]   [Full Text] [Related]  

  • 29. The therapy of Hodgkin's disease in Nigeria: a five year study.
    Oluboyede OA; Esan GJ
    Afr J Med Med Sci; 1976 Sep; 5(3):201-7. PubMed ID: 829730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Current status of chemotherapy for Hodgkin's disease].
    Löffler H; Gassmann W; Schmitz N; Pralle H
    Med Welt; 1981 Jun; 32(25):1010-6. PubMed ID: 7278578
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical and hematological characteristics and MOPP tolerance of patients with Hodgkin's lymphoma in the bone marrow].
    Fiacchini M; Lauria F; Mazza P; Tura S
    Haematologica; 1982 Jun; 67(3):394-401. PubMed ID: 6814996
    [No Abstract]   [Full Text] [Related]  

  • 32. The treatment of advanced Hodgkin's disease at Memorial Hospital.
    Straus DJ; Young CW; Lee BJ; Koziner B; Clarkson BD; Nisce LZ
    Clin Bull; 1980; 10(4):138-43. PubMed ID: 7214703
    [No Abstract]   [Full Text] [Related]  

  • 33. [Evaluation of the bone marrow granulocyte reserve in patients with Hodgkin's disease during antiblastic polychemo- and radiation therapy].
    Santagati G; Nicolini E; Zibetti G; Paladini G
    Minerva Med; 1978 May; 69(25):1739-43. PubMed ID: 662176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Relapses in Hodgkin's disease and their radiochemotherapy (author's transl)].
    Babini L; Sciascia R; Baccarani M; Emiliani E; Fiacchini M; Franchini A; Lauria F; Tura S
    Radiol Med; 1978 Feb; 64(2):113-8. PubMed ID: 684251
    [No Abstract]   [Full Text] [Related]  

  • 35. [Life expectancy in Hodgkin's disease].
    Bernadou A; Bousser J
    Rev Prat; 1974 Oct; 24(45):3999-4002. PubMed ID: 4445769
    [No Abstract]   [Full Text] [Related]  

  • 36. The response rate at chemotherapy in advanced Hodgkin's disease reflected by peripheral lymphocyte count.
    Krizan Z; Korec S; Bohunický L
    Neoplasma; 1978; 25(6):737-9. PubMed ID: 752119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary treatment of Hodgkin's disease with sequential radiation therapy and multidrug chemotherapy without initial laparotomy--splenectomy.
    Lacher MJ
    Prog Clin Cancer; 1982; 8():283-97. PubMed ID: 7156405
    [No Abstract]   [Full Text] [Related]  

  • 38. [The use of betamethasone in polychemotherapy of lymphoproliferative diseases].
    Cellerino R; Ambrosetti A; Tummarello D; Perini A; Piga A; Celebrano M
    Minerva Med; 1980 Sep; 71(32):2293-7. PubMed ID: 6933321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hodgkin's disease and hematosarcomas. Treatment trial by 2 methylhydrazines].
    Mathe G; Schneider M; Amiel JL; Schwarzenberg L; Cattan A; Schlumberger JR
    Concours Med; 1965 Jul; 87(27):4555-62. PubMed ID: 5841618
    [No Abstract]   [Full Text] [Related]  

  • 40. Combination chemotherapy in Hodgkin's disease.
    Nordentoft AM; Jensen KB
    Dan Med Bull; 1973 Mar; 20(2):52-60. PubMed ID: 4688460
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.